Saudi experience in the management of pulmonary arterial hypertension; the outcome of PAH therapy with the exclusion of chronic parenteral prostacyclin

Saudi experience in the management of pulmonary arterial hypertension; the outcome of PAH therapy with the exclusion of chronic parenteral prostacyclin

Aims: The purpose of this study is to present our center′s experience in managing patients with pulmonary arterial hypertension (PAH). The main objective is to describe patients′ management profile and treatment outcome. Methods: This study presents the results from a single pulmonary hypertension...

Full description

Bibliographic Details
Main Authors: Majdy Idrees, Khalid Alnajashi, Jasim Abdulhameed, Atika Khan, Enas Batubara, Abdelmajeed Alotay, Amal Fayed, Saleh Aldammas, Moaad Alseif, Husam Alawwad, Yahya Abusabaa, Mashael Almobrad, Tarek Kashour, The Registry Taskforce SAPH
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-01-01
Series:Annals of Thoracic Medicine
Subjects:
Mortality
prostacyclin
pulmonary arterial hypertension
Saudi association for pulmonary hypertension
target therapy
Online Access:http://www.thoracicmedicine.org/article.asp?issn=1817-1737;year=2015;volume=10;issue=3;spage=204;epage=211;aulast=Idrees

Internet

http://www.thoracicmedicine.org/article.asp?issn=1817-1737;year=2015;volume=10;issue=3;spage=204;epage=211;aulast=Idrees

Similar Items